GPCR
Price
$28.25
Change
-$0.33 (-1.15%)
Updated
Dec 24, 02:00 PM (EDT)
ROIV
Price
$12.00
Change
+$0.03 (+0.25%)
Updated
Dec 24, 02:00 PM (EDT)
55 days until earnings call
Ad is loading...

GPCR vs ROIV

Header iconGPCR vs ROIV Comparison
Open Charts GPCR vs ROIVBanner chart's image
Structure Therapeutics
Price$28.25
Change-$0.33 (-1.15%)
Volume$29.35K
CapitalizationN/A
Roivant Sciences
Price$12.00
Change+$0.03 (+0.25%)
Volume$138.71K
CapitalizationN/A
GPCR vs ROIV Comparison Chart
Loading...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GPCR vs. ROIV commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Buy and ROIV is a Buy.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (GPCR: $28.58 vs. ROIV: $11.97)
Brand notoriety: GPCR and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 80% vs. ROIV: 162%
Market capitalization -- GPCR: $1.64B vs. ROIV: $8.42B
GPCR [@Biotechnology] is valued at $1.64B. ROIV’s [@Biotechnology] market capitalization is $8.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 1 green FA rating(s).

  • GPCR’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 1 green, 4 red.
According to our system of comparison, ROIV is a better buy in the long-term than GPCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • GPCR’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GPCR is a better buy in the short-term than ROIV.

Price Growth

GPCR (@Biotechnology) experienced а -7.81% price change this week, while ROIV (@Biotechnology) price change was -1.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.99%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +3.17%.

Reported Earning Dates

GPCR is expected to report earnings on Nov 14, 2024.

ROIV is expected to report earnings on Feb 17, 2025.

Industries' Descriptions

@Biotechnology (-0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.42B) has a higher market cap than GPCR($1.64B). ROIV YTD gains are higher at: 6.589 vs. GPCR (-29.882). ROIV has higher annual earnings (EBITDA): 4.15B vs. GPCR (-141.37M). ROIV has more cash in the bank: 5.39B vs. GPCR (915M). GPCR has less debt than ROIV: GPCR (4.39M) vs ROIV (52.7M). ROIV has higher revenues than GPCR: ROIV (129M) vs GPCR (0).
GPCRROIVGPCR / ROIV
Capitalization1.64B8.42B19%
EBITDA-141.37M4.15B-3%
Gain YTD-29.8826.589-453%
P/E RatioN/A2.16-
Revenue0129M-
Total Cash915M5.39B17%
Total Debt4.39M52.7M8%
TECHNICAL ANALYSIS
Technical Analysis
GPCRROIV
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 16 days ago
88%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 6 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
N/A
View a ticker or compare two or three
Ad is loading...
GPCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRLGX84.100.64
+0.77%
T. Rowe Price Lrg Cp Gr I
NBHAX13.350.05
+0.38%
Neuberger Berman Equity Income A
PJDCX16.650.06
+0.36%
PGIM Jennison Rising Dividend C
OGIYX49.030.04
+0.08%
Invesco Global Opportunities Y
TZINX2.40N/A
N/A
Templeton Global Balanced Adv

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been loosely correlated with AFMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GPCR jumps, then AFMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+2.44%
AFMD - GPCR
43%
Loosely correlated
N/A
CKPT - GPCR
43%
Loosely correlated
-5.60%
CARA - GPCR
40%
Loosely correlated
+8.23%
CRNX - GPCR
34%
Loosely correlated
+0.67%
ROIV - GPCR
33%
Poorly correlated
+3.46%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+3.46%
IMVT - ROIV
58%
Loosely correlated
-0.39%
ARGX - ROIV
46%
Loosely correlated
+0.72%
AXON - ROIV
43%
Loosely correlated
-1.20%
RARE - ROIV
42%
Loosely correlated
-0.79%
ALDX - ROIV
42%
Loosely correlated
-1.84%
More